Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Beer, wine or spirits: A large study finds different mortality patterns for each (opens in a new tab)

news-medical.net · 2026-10-25

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 3 supported
  • 4 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Three of seven claims match the study. This overall rating is based only on the claims we could check. Four claims the study doesn't address.

  • 3 supported
  • 4 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

7 claims in this story

Showing all 7 claimsChoose a verdict to focus the list.

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Moderate-to-high total alcohol and beer/cider/spirits intake, and high wine intake, were associated with higher mortality from multiple site-specific cancers.

    The story discusses broad cancer or cause-specific mortality but does not clearly convey the abstract's separate site-specific cancer mortality component or the listed cancer-site scope.

    From Prospective cohort (secondary data analysis of UK Biobank)

  • For beverage-specific and site-specific cancer analyses, the abstract omits detailed effect estimates, full model details, multiplicity handling, and site-specific event counts.

    The story mentions general residual confounding but does not reflect the abstract-depth limitations around sparse reporting, multiple endpoints, and lack of detailed site-specific estimates.

    From Prospective cohort (UK Biobank); beverage-specific Cox proportional hazards models; Prospective cohort (secondary data a

7 things the story did carry across
  • Prospective UK Biobank cohort of 340,924 participants followed through 2022, using Cox proportional hazards models to assess alcohol intake and mortality.
  • High total alcohol intake versus never/occasional intake was associated with higher all-cause, cardiovascular, cancer, and other-cause mortality.
  • Moderate total alcohol intake was associated with higher cancer mortality.
  • Beverage-specific findings differed: beer/cider and spirits showed adverse associations, while low-to-moderate wine intake showed inverse associations for broad mortality outcomes.
  • The evidence is observational and should be interpreted as association rather than proof of causation.
  • Abstract-level limitations include unspecified covariate adjustment and possible residual confounding.
  • Exposure information in the abstract is baseline alcohol categorization, with potential changes in alcohol intake over follow-up not described.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataEstimate associations of total alcohol intake level at mid-life with all-cause and cause-specific mortality (all-cause, CVD, cancer, other) in UK Biobank.Prospective cohort (secondary data) — UK BiobankExpand

In plain English

Prospective cohort analysis of 340,924 UK Biobank participants (2006–2022) examining associations between baseline total alcohol intake (sex-specific categorized levels) and subsequent all-cause and cause-specific (CVD, cancer, other) mortality using Cox proportional hazards models. Over a mean 13.4-year follow-up there were 22,381 deaths. High total alcohol intake (vs never/occasional) was associated with higher all-cause, CVD, cancer, and other mortality; moderate intake was associated with higher cancer mortality. Beverage-specific contrasts in the abstract indicate adverse associations for spirits and beer/cider even at low-to-moderate levels, and inverse associations for low-to-moderate wine intake, while high intake (overall and by beverage for some comparisons) was linked to elevated site-specific cancer mortality.

Key findings

  • High total alcohol intake (vs never/occasional) was associated with higher all-cause mortality.HR 1.24 (95% CI 1.17–1.31)
  • High total alcohol intake (vs never/occasional) was associated with higher cardiovascular disease mortality.HR 1.14 (95% CI 1.01–1.28)
“We included 340,924 participants from UK Biobank (2006-2022).”
What this piece can’t prove

3 further details could not be confirmed from the summary.

2secondary dataEstimate beverage-specific associations (beer/cider, spirits, wine) of alcohol intake level with all-cause and cause-specific mortality (all-cause, CVD, cancer, other).Prospective cohort (UK Biobank); beverage-specific Cox proportional hazards modelsExpand

In plain English

In a prospective analysis of 340,924 UK Biobank participants (2006–2022, mean follow-up 13.4 years), beverage-specific alcohol intake was categorized into intake levels and related to all-cause and cause-specific mortality using Cox proportional hazards models. Alcohol from spirits and beer/cider, even at low-to-moderate levels, was reported to be associated with higher all-cause, cardiovascular, cancer, and other mortality (HRs reported in the abstract to range 1.07–1.83). By contrast, low-to-moderate intake from wine was reported to be associated with lower all-cause, CVD, cancer, and other mortality; however, high intake (overall and for some beverage types) was associated with higher mortality from multiple site-specific cancers.

Key findings

  • Alcohol from spirits and beer/cider, even at low-to-moderate intake levels, was associated with higher mortality from all causes, cardiovascular disease, cancer, and other causes.HRs reported in abstract ranging 1.07–1.83
  • Low and moderate alcohol intake from wine was associated with lower all-cause, cardiovascular, cancer, and other mortality in the reported analyses.
“Alcohol consumption from spirits and beer/cider, even at low to moderate levels, was associated with higher mortality from all-causes, CVD, cancer, and other diseases...”
3secondary dataAssess associations of total and beverage-specific alcohol intake levels with site-specific cancer mortality (multiple cancer sites).Prospective cohort (secondary data analysis of UK Biobank)Expand

In plain English

In UK Biobank prospective data (n=340,924; mean follow-up 13.4 years), the authors report that moderate-to-high total alcohol intake and alcohol from beer/cider and spirits, and high wine intake, were each associated with higher mortality from multiple site-specific cancers (including head/neck, respiratory, gastrointestinal, liver/gallbladder, hematological, female breast, and female/male genital cancers).

Key findings

  • Moderate-to-high total alcohol intake and alcohol from beer/cider and spirits, and high wine intake, were reported as particularly associated with higher mortality from multiple site-specific cancers (listed in the abstract).
“Importantly, moderate to high intake of total alcohol and alcohol from beer/ cider and spirits, and high wine use were particularly associated with higher mortality from multiple site-specific cancers...”
What this piece can’t prove
  • Abstract does not describe covariate adjustment set or sensitivity analyses (e.g., competing risks, lagging exposure, or exclusion of prevalent disease).
  • Interpretation of beverage-specific associations for individual cancer sites may be limited by unreported site-level event counts and model specification details.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref, Europe PMC · 15 candidate papers

And 9 more candidates considered.